These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 18550035)

  • 1. Seizure responses and induction of Fos by the NMDA agonist (tetrazol-5-yl)glycine in a genetic model of NMDA receptor hypofunction.
    Duncan GE; Inada K; Farrington JS; Koller BH
    Brain Res; 2008 Jul; 1221():41-8. PubMed ID: 18550035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of NMDA receptor activation in vivo by Fos induction after challenge with the direct NMDA agonist (tetrazol-5-yl)glycine: effects of clozapine and haloperidol.
    Inada K; Farrington JS; Moy SS; Koller BH; Duncan GE
    J Neural Transm (Vienna); 2007 Jul; 114(7):899-908. PubMed ID: 17318306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neural activation deficits in a mouse genetic model of NMDA receptor hypofunction in tests of social aggression and swim stress.
    Duncan GE; Inada K; Farrington JS; Koller BH; Moy SS
    Brain Res; 2009 Apr; 1265():186-95. PubMed ID: 19232330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased sensitivity to kainic acid in a genetic model of reduced NMDA receptor function.
    Duncan GE; Inada K; Koller BH; Moy SS
    Brain Res; 2010 Jan; 1307():166-76. PubMed ID: 19840778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amphetamine-induced Fos is reduced in limbic cortical regions but not in the caudate or accumbens in a genetic model of NMDA receptor hypofunction.
    Miyamoto S; Snouwaert JN; Koller BH; Moy SS; Lieberman JA; Duncan GE
    Neuropsychopharmacology; 2004 Dec; 29(12):2180-8. PubMed ID: 15467708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in regional brain metabolism in genetic and pharmacological models of reduced NMDA receptor function.
    Duncan G; Miyamoto S; Gu H; Lieberman J; Koller B; Snouwaert J
    Brain Res; 2002 Oct; 951(2):166-76. PubMed ID: 12270494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D,L-(tetrazol-5-yl) glycine: a novel and highly potent NMDA receptor agonist.
    Schoepp DD; Smith CL; Lodge D; Millar JD; Leander JD; Sacaan AI; Lunn WH
    Eur J Pharmacol; 1991 Oct; 203(2):237-43. PubMed ID: 1686860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-Methyl-D-aspartate-induced c-Fos expression is enhanced in the forebrain structures related to emotion in Fyn-deficient mice.
    Hattori K; Yagi T; Maekawa M; Sato T; Yuasa S
    Brain Res; 2001 Jun; 905(1-2):188-98. PubMed ID: 11423094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased susceptibility to seizures induced by pentylenetetrazole in serine racemase knockout mice.
    Harai T; Inoue R; Fujita Y; Tanaka A; Horio M; Hashimoto K; Hongou K; Miyawaki T; Mori H
    Epilepsy Res; 2012 Dec; 102(3):180-7. PubMed ID: 22742962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model for schizophrenia.
    Halene TB; Ehrlichman RS; Liang Y; Christian EP; Jonak GJ; Gur TL; Blendy JA; Dow HC; Brodkin ES; Schneider F; Gur RC; Siegel SJ
    Genes Brain Behav; 2009 Oct; 8(7):661-75. PubMed ID: 19563516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-methyl-D-aspartate autoreceptors respond to low and high agonist concentrations by facilitating, respectively, exocytosis and carrier-mediated release of glutamate in rat hippocampus.
    Luccini E; Musante V; Neri E; Raiteri M; Pittaluga A
    J Neurosci Res; 2007 Dec; 85(16):3657-65. PubMed ID: 17671992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amphetamine-induced disruption of prepulse inhibition in mice with reduced NMDA receptor function.
    Moy SS; Perez A; Koller BH; Duncan GE
    Brain Res; 2006 May; 1089(1):186-94. PubMed ID: 16638606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMDA receptor subunit NR1-immunoreactivity in the rat pons and brainstem and colocalization with Fos induced by nasal stimulation.
    Dutschmann M; Guthmann A; Herbert H
    Brain Res; 1998 Nov; 809(2):221-30. PubMed ID: 9853114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NR1 knockdown mice as a representative model of the glutamate hypothesis of schizophrenia.
    Ramsey AJ
    Prog Brain Res; 2009; 179():51-8. PubMed ID: 20302817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization of glycine-activated currents in HEK 293 cells expressing N-methyl-D-aspartate NR1 and NR3 subunits.
    Smothers CT; Woodward JJ
    J Pharmacol Exp Ther; 2007 Aug; 322(2):739-48. PubMed ID: 17502428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatiotemporal analysis of Fos expression associated with cocaine- and PTZ-induced seizures in prenatally cocaine-treated rats.
    Snyder-Keller A; Keller RW
    Exp Neurol; 2001 Jul; 170(1):109-20. PubMed ID: 11421588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Typical and atypical antipsychotic drug effects on locomotor hyperactivity and deficits in sensorimotor gating in a genetic model of NMDA receptor hypofunction.
    Duncan GE; Moy SS; Lieberman JA; Koller BH
    Pharmacol Biochem Behav; 2006 Nov; 85(3):481-91. PubMed ID: 17097724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conditional deletion of the NMDA-NR1 receptor subunit gene in the central nucleus of the amygdala inhibits naloxone-induced conditioned place aversion in morphine-dependent mice.
    Glass MJ; Hegarty DM; Oselkin M; Quimson L; South SM; Xu Q; Pickel VM; Inturrisi CE
    Exp Neurol; 2008 Sep; 213(1):57-70. PubMed ID: 18614169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of functional NR1/NR2B-type NMDA receptors in neuronally differentiated SK-N-SH human cell line.
    Pizzi M; Boroni F; Bianchetti A; Moraitis C; Sarnico I; Benarese M; Goffi F; Valerio A; Spano P
    Eur J Neurosci; 2002 Dec; 16(12):2342-50. PubMed ID: 12492429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of haloperidol, clozapine, and quetiapine on sensorimotor gating in a genetic model of reduced NMDA receptor function.
    Duncan GE; Moy SS; Lieberman JA; Koller BH
    Psychopharmacology (Berl); 2006 Jan; 184(2):190-200. PubMed ID: 16362405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.